FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nobuko Ishii

Research Profile

Disorders

Anatomy

Tumor Cells, Cultured

Chemicals & Drugs

Procedures

Genetic Therapy

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Kumi Hirano; Tatsuki Ichikawa; Kazuhiko Nakao; Azusa Matsumoto; Hisamitsu Miyaaki; Hidetaka Shibata; Susumu Eguchi; Mitsuhisa Takatsuki; Masanori Ikeda; Hironori Yamasaki; Nobuyuki Kato; Takashi Kanematsu; Nobuko Ishii; Katsumi Eguchi
Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Akira Saeki; Kazuhiko Nakao; Yuji Nagayama; Kenji Yanagi; Kojiro Matsumoto; Toshinobu Hayashi; Hiroki Ishikawa; Keisuke Hamasaki; Nobuko Ishii; Katsumi Eguchi
Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma.
Masaya Shigeno; Kazuhiko Nakao; Tatsuki Ichikawa; Kasumi Suzuki; Atsushi Kawakami; Seigo Abiru; Seiji Miyazoe; Yuichi Nakagawa; Hiroki Ishikawa; Keisuke Hamasaki; Keisuke Nakata; Nobuko Ishii; Katsumi Eguchi
Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nobuko Ishii (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Kumi Hirano; Tatsuki Ichikawa; Kazuhiko Nakao; Azusa Matsumoto; Hisamitsu Miyaaki; Hidetaka Shibata; Susumu Eguchi; Mitsuhisa Takatsuki; Masanori Ikeda; Hironori Yamasaki; Nobuyuki Kato; Takashi Kanematsu; Nobuko Ishii; Katsumi Eguchi
Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(3):292-8.
2004: Akira Saeki; Kazuhiko Nakao; Yuji Nagayama; Kenji Yanagi; Kojiro Matsumoto; Toshinobu Hayashi; Hiroki Ishikawa; Keisuke Hamasaki; Nobuko Ishii; Katsumi Eguchi
Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma.
International journal of molecular medicine 2004;13(1):111-6.
2003: Masaya Shigeno; Kazuhiko Nakao; Tatsuki Ichikawa; Kasumi Suzuki; Atsushi Kawakami; Seigo Abiru; Seiji Miyazoe; Yuichi Nakagawa; Hiroki Ishikawa; Keisuke Hamasaki; Keisuke Nakata; Nobuko Ishii; Katsumi Eguchi
Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
Oncogene 2003;22(11):1653-62.
2003: Kenji Yanagi; Yuji Nagayama; Kazuhiko Nakao; Akira Saeki; Koujirou Matsumoto; Tatsuki Ichikawa; Hiroki Ishikawa; Keisuke Hamasaki; Nobuko Ishii; Katsumi Eguchi
Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo.
International journal of oncology 2003;22(2):345-51.
2002: Tatsuki Ichikawa; Kazuhiko Nakao; Keisuke Nakata; Mayumi Yamashita; Keisuke Hamasaki; Masaya Shigeno; Seigo Abiru; Hiroki Ishikawa; Nobuko Ishii; Katsumi Eguchi
Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.
Biochemical and biophysical research communications 2002;294(2):414-22.
2002: Tetsuhiko Arima; Kazuhiko Nakao; Keisuke Nakata; Hiroki Ishikawa; Tatsuki Ichikawa; Keisuke Hamasaki; Nobuko Ishii; Katsumi Eguchi
Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
International journal of molecular medicine 2002;9(4):397-400.
2001: Hiroki Ishikawa; Keisuke Nakata; F Mawatari; T Ueki; S Tsuruta; Akio Ido; Kazuhiko Nakao; Yuji Kato; Nobuko Ishii; Katsumi Eguchi
Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Biochemical and biophysical research communications 2001;287(4):1034-40.
2001: Tatsuki Ichikawa; Kazuhiko Nakao; Keisuke Nakata; Keisuke Hamasaki; Yoshio Takeda; Yuji Kajiya; Shinnichirou Higashi; Kazuaki Ohkubo; Yuji Kato; Nobuko Ishii; Katsumi Eguchi
Geranylgeranylacetone induces antiviral gene expression in human hepatoma cells.
Biochemical and biophysical research communications 2001;280(3):933-9.
2000: K Iseki; Kazuhiko Nakao; Keisuke Nakata; Y Shima; Keisuke Hamasaki; Y Kato; Nobuko Ishii; Katsumi Eguchi
Diverse regulations of albumin gene expression by hepatocyte growth factor in HepG2 human hepatoma cells and primary culture of rat hepatocytes.
International journal of oncology 2000;16(6):1141-5.
1999: Hiroki Ishikawa; Keisuke Nakata; F Mawatari; T Ueki; S Tsuruta; Akio Ido; Kazuhiko Nakao; Yuji Kato; Nobuko Ishii; Katsumi Eguchi
Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
Gene therapy 1999;6(4):465-70.
1998: D Hida; Keisuke Nakata; Y Shima; K Migita; Kazuhiko Nakao; Yuji Kato; Nobuko Ishii; Katsumi Eguchi
Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of the cdk family, in HuH-7 human hepatoma cells.
Anticancer research 1998;18(6A):4317-22.
1998: F Mawatari; S Tsuruta; Akio Ido; T Ueki; Kazuhiko Nakao; Yuji Kato; Taiki Tamaoki; Nobuko Ishii; Keisuke Nakata
Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Cancer gene therapy 1998;5(5):301-6.
1998: T Ueki; Keisuke Nakata; F Mawatari; S Tsuruta; Akio Ido; Hiroki Ishikawa; Kazuhiko Nakao; Yuji Kato; Nobuko Ishii; Katsumi Eguchi
Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.
International journal of molecular medicine 1998;1(4):671-5.
1997: K Yano; Kazuhiko Nakao; K Sayama; Keisuke Hamasaki; Yuji Kato; Keisuke Nakata; Nobuko Ishii; J H Butterfield; S J Galli
The HMC-1 human mast cell line expresses the hepatocyte growth factor receptor c-met.
Biochemical and biophysical research communications 1997;239(3):740-5.
1995: Akio Ido; Keisuke Nakata; Yuji Kato; Kazuhiko Nakao; K Murata; M Fujita; Nobuko Ishii; T Tamaoki; H Shiku; S Nagataki
Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Cancer research 1995;55(14):3105-9.
1993: Y Sato; Keisuke Nakata; Yuji Kato; M Shima; Nobuko Ishii; T Koji; K Taketa; Y Endo; S Nagataki
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
The New England journal of medicine 1993;328(25):1802-6.
1992: S Tsuruta; Keisuke Nakata; N Ohata; Y Gondo; Y Sato; T Nakayama; Kazuhiko Nakao; M Shima; Nobuko Ishii; Takehiko Koji
Enhanced DNA synthesis in rat hepatoma cells by conditioned media from Kupffer cells incubated with supernatants of tumor necrosis factor-alpha-pretreated hepatocytes.
Biochemical and biophysical research communications 1992;183(3):1147-52.
1992: Keisuke Hamasaki; Keisuke Nakata; Kazuhiko Nakao; S Mitsuoka; T Tsutsumi; Yuji Kato; M Shima; Nobuko Ishii; T Tamaoki; S Nagataki
Interaction of interferon-alpha with interleukin-1 beta or tumor necrosis factor-alpha on hepatitis B virus enhancer activity.
Biochemical and biophysical research communications 1992;183(2):904-9.